Lori Wiviott Tishler, MD, MPH

Lori Tishler, MD MPH is a general internist at Brigham and Women’s Hospital and Assistant Professor at Harvard Medical School. In addition to caring for a large panel of patients, Dr. Tishler is the medical director of the hospital’s largest practice. Clinically, her interests include preventive medicine, the interface between physical and behavioral health, and culturally competent, humanistic care. Dr. Tishler’s non clinical work is focused on improving care delivery, value, and operational efficiency. She also thinks a lot about improving physician quality of life, decreasing burnout, and improving resiliency. She teaches and mentors residents and medical students. Outside of work, Dr. Tishler loves to spend time with her family, travel, do puzzles, and read.

Posts by Lori Wiviott Tishler, MD, MPH

Drug-resistant bacteria a growing health problem

Lori Wiviott Tishler, MD, MPH
Lori Wiviott Tishler, MD, MPH, Assistant Professor of Medicine, Harvard Medical School

Antibiotic-resistant bacteria sicken more than two million Americans each year and account for at least 23,000 deaths. The main cause? Overuse of antibiotics. A new report from the Centers for Disease Control and Prevention, Antibiotic Resistance Threats in the United States, 2013, details the health and financial costs of antibiotic resistance in the United States. In terms of health, antibiotic resistance should be in the CDC’s top 15 causes of death. It also adds as much as $20 billion in direct health-care costs. And the problem could get worse before it gets better. Antibiotic resistance is a problem because commonly used antibiotics will become less able to treat common infections. The CDC identified three types of bacteria as urgent hazards: Clostridium difficile, Enterobacteriaceae, and Neisseria gonorrhoeae. Decreasing the use of antibiotics and preventing infection in the first place are two key steps to halting the problem.